… However, in the absence of randomized trials specifically addressing the value of chemoradiation
in elderly patient cohorts we feel that it adds valuable information to the existing body …

… the disparity of inferior health outcomes and quality of life seen in elderly patients [13]. The
… of age on clinical outcomes of patients with LARC treated with neoadjuvant chemoradiation (…

… The optimal treatment approach for patients ≥80 years (“elderly”) with esophageal cancer is
… We assessed the clinical outcomes in elderly patients treated with definitive chemoradiation …

… results showed that CRT in elderly patients produced a similar response rate and overall
survival as usually reported in younger patients … be discussed in elderly patients. Improvements …

… (NSCLC) patients aged 70 years or older with comorbidities. … clinical outcomes between
concurrent chemoradiotherapy (… patients (≥70 years) in a single institution’s clinical practice. …

… CRT was suboptimal particularly for elderly patients. To improve the treatment compliance
of standard CRT in elderly patients, we introduced chemotherapy dose modifications. …

… (CRT) for head and neck squamous cell carcinoma patients older than 70 years is debated.
This study examines the outcomes of elderly patients receiving CRT versus radiotherapy (RT…

… Preoperative chemoradiotherapy … chemoradiotherapy is truly beneficial in the elderly patients.
Our aim was to assess the impact of age on the treatment tolerance and clinical outcomes. …

… bias of our retrospective analysis as chemotherapy may have been more often … elderly
patients. Nevertheless, the percentages of patients that completed the prescribed chemotherapy …

… elderly patients. The aim of the present study was to evaluate the clinical outcomes of elderly
patients (over 80 years old… -arterial infusion chemotherapy concurrent with radiotherapy at a …